Active Ingredient Ocrelizumab
Active Ingredient Details
What is the usage for Ocrelizumab?
Ocrelizumab is used to treat certain forms of multiple sclerosis-MS (relapsing or primary progressive forms). It is not a cure for MS, but it is thought to help slow down nerve damage, reduce the number of relapses, and delay disability. Ocrelizumab belongs to a class of drugs known as monoclonal antibodies.
How many products in the NDC database contain Ocrelizumab?
The NDC database has 4 products with the active ingredient Ocrelizumab. The following table lists all the products that have this active ingredient.
NDC Products with Ocrelizumab
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 50242-150 | Proprietary Name: Ocrevus | Ocrelizumab | Injection | Intravenous | Genentech, Inc. | ACTIVE | |
| 50242-554 | Proprietary Name: Ocrevus Zunovo | Ocrelizumab And Hyaluronidase | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
| 67643-7000 | Proprietary Name: | Ocrelizumab | Liquid | Lonza Biologics, Inc. | ACTIVE | ||
| 67643-7001 | Proprietary Name: | Ocrelizumab | Liquid | Lonza Biologics, Inc. | ACTIVE |
